Articles by Patricia Van Arnum - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Patricia Van Arnum

Pharma's Year in Review

Pharmaceutical Technology takes a look at the major deals and moves of 2013.
Dec 4, 2013

Pharmaceutical Technology takes a look at the major deals and moves of 2013.

The Global Divide in Pharma Industry Growth

Dec 4, 2013

Global spending on medicines is expected to meet the $1 trillion threshold in 2014 and reach $1.17 trillion by 2017, according to a recent report by the IMS Institute for Healthcare Informatics

Tracking Innovation in New Molecular Entities of 2013

A review of this years crop of the new molecular entities and new biologics license applications approved by FDA thus far in 2013.
Dec 2, 2013

A review of this year's crop of the new molecular entities and new biologics license applications approved by FDA thus far in 2013.

GlaxoSmithKline Invests in India

Nov 22, 2013

GlaxoSmithKline will build a new solid dosage manufacturing facility in India.

Pharmaceutical Industry Growth Rebounds in Five-Year Outlook

Nov 22, 2013

Annual growth in spending for medicines is expected to rise from 2-3% in 2013 to 5-7% in 2017, the highest pace of growth since 2009.

Overcoming Challenges in Fluorine-Based Chemistry

Fluorinated molecules are important as pharmaceutical compounds. Recent advances involve selective and late-stage insertion of fluorine into small molecules.
Nov 13, 2013

Fluorinated molecules are important as pharmaceutical compounds. Recent advances involve selective and late-stage insertion of fluorine into small molecules.

Pfizer, Carter Center Partner in Global Health Project

Nov 11, 2013

Former President Jimmy Carter and Pfizer mark milestone for long-standing partnership to combat trachoma in the developing world.

Fine-Chemical Companies, CDMOs and CMOs Expand

A roundup of expansion activity of manufacturing capacity and service offerings from fine-chemical producers, CDMOs, and CMOs.
Nov 6, 2013

A roundup of expansion activity of manufacturing capacity and service offerings from fine-chemical producers, CDMOs, and CMOs.

A Strong Outlook for Global Pharma Outsourcing

Overall growth in the market for pharmaceutical contract research and manufacturing is strong although growth in established markets erodes at the expense of emerging markets.
Nov 6, 2013

Overall growth in the market for pharmaceutical contract research and manufacturing is strong although growth in established markets erodes at the expense of emerging markets.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here